PML Peptide

Catalog Number

350546

Unit

0.1 mg

Price

$50.00

Description

Promyelocytic leukemia protein (PML) is a transcription factor involved in transcriptional regulation and nuclear protein sequestration, such as recruiting ELF4 into PML nuclear bodies. A chromosomal aberration involving PML is a cause of acute promyelocytic leukemia.

Format

Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.

Data and Images

Product Citations

Recommended Products

200184 PML Antibody

Alternate Names

Probable transcription factor PML; Tripartite motif-containing protein 19; RING finger protein 71; PML; MYL; RNF71; TRIM19; Promyelocytic leukemia protein

Accession No.

P29590
NP_150241

MW

1963.1 g/mol

Sequence

The synthetic peptide used to raise the antibody Cat. No. 200184 is selected from a sequence within the N-term region of human PML. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.

Composition

C80H131N29O27S1

Purity

Purity > 80% by HPLC

Solubility

Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.

Storage

Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.

For research use only, not for diagnostic or therapeutic procedures.